CSG's Ammo Division Stumbles, Yet the Defence Giant's Half-Year Numbers Tell a Different Story
Published on 08/10/2026 at 18:41 | Redaktion boerse-global.de
The Czechoslovak Group delivered a set of half-year results on Monday that would normally have investors reaching for champagne — a net profit surge of nearly 85 percent, a 17.2 percent jump in group revenue, and an order book stretching to a record €46 billion. Instead, the shares slipped, and the culprit was hiding in plain sight: the ammunition business.
Ammo+, the group's munitions arm, saw first-half revenue fall 11.5 percent to €631 million, down from €713 million a year earlier. The operating result took an even harder knock, sliding 26.7 percent to €51 million. The division's operating margin now sits at 8.1 percent — a figure that looks modest next to the group's 24.1 percent overall margin, though it does mark a meaningful improvement from the 4.5 percent recorded in the first quarter, suggesting the worst may be over.
A Group in Overdrive
Strip out the ammunition weakness, and the picture is one of a defence contractor firing on all cylinders. Group revenue climbed to €3.251 billion in the first six months, while EBIT rose 12.7 percent to €784 million. Net profit from continuing operations jumped 84.8 percent to €572.3 million — comfortably ahead of the analyst consensus of €3.14 billion in revenue and €764 million in EBIT.
The second quarter was particularly strong, with revenue up 20.3 percent to roughly €1.71 billion, EBIT advancing 16.5 percent to €413 million, and net profit nearly doubling with a 94.2 percent gain to €272 million. The contrast between a flagging munitions division and a booming parent company underscores just how diversified the group has become — other business segments are more than compensating for Ammo+'s struggles.
When businesses expand as rapidly as CSG has, new operational risks emerge just as quickly — and documenting them properly becomes a serious challenge. A free toolkit with 41 ready-to-use templates, checklists, and training materials can help you keep your risk assessments current and compliant without the administrative headache. Download the free Risk Assessment Toolkit
Record Backlog, Confirmed Guidance
Management reaffirmed its full-year 2026 outlook, targeting revenue between €7.4 billion and €7.6 billion with an operating EBIT margin of 24 to 25 percent. That guidance rests on a formidable foundation: the order backlog and pipeline together reached €46 billion as of June 30, up from €44 billion in March. The Defence Systems segment, which saw revenue expand 27 percent, is the primary engine behind this growth.
US orders have provided some relief for the ammunition unit. A contract with the FBI for rifle ammunition is worth $77 million, and combined orders from US federal and law enforcement agencies total roughly $100 million. These bookings bolster the division's order book but have not been enough to offset the core business decline.
Strategic Moves on Multiple Fronts
Beyond the numbers, the group has been busy reshaping its portfolio. On Friday, CSG announced a minority stake in North Vector Dynamics Inc., a Canadian developer of missile systems and autonomous technology, aimed at strengthening its air defence and precision interception capabilities.
Earlier in August, the group completed the acquisition of the 57-hectare Gnaschwitz industrial site in Saxony from Maxam. CSG plans to invest more than €100 million there to build production capacity for nitroglycerin and ammunition components — a move that significantly deepens its European manufacturing footprint. The group also unveiled plans on July 31 for a new technology centre in the Czech Republic, focused on developing AviaNera propulsion systems for unmanned aerial vehicles.
Financial and Leadership Refresh
The balance sheet has also been streamlined. On July 28, CSG closed the refinancing of its senior credit lines into a single unsecured investment-grade facility of €3.06 billion. The move cuts borrowing costs by 125 to 150 basis points and extends maturities to six years, giving the group additional firepower for further acquisitions without straining its leverage.
On the personnel front, Ben Hudson officially joined the board on August 1 as a member, vice chairman, and chief technology officer, taking responsibility for land defence capabilities and research and development.
Market Reaction and Analyst Support
The shares traded down 3.06 percent at €17.55 on Monday, following Friday's close of €18.11. That pullback comes after a remarkable 28.54 percent rally over the prior 30 days — and it leaves the stock still 51.31 percent below its 52-week high of €36.05, reached in late January. The gap between operational strength and share price performance remains striking.
Analysts, however, are taking a constructive view. J&T Banka initiated coverage on Friday with a buy recommendation and a twelve-month price target of €32.00, well above the current trading level.
As CSG's experience shows, even the strongest operational performance can be undermined by a single weak division. The same logic applies to workplace safety: one overlooked hazard can undo years of good practice. Over 37,000 UK businesses already use a free health and safety toolkit covering everything from fire safety to COSHH compliance to protect their teams and their reputations. Get the free Health & Safety Toolkit
The question hanging over the stock is whether Ammo+'s decline is a temporary blip or something more structural. The sequential margin improvement from 4.5 to 8.1 percent offers some comfort, but until that question is resolved with greater clarity, investors may continue to weigh the group's impressive headline numbers against the nagging weakness in its ammunition franchise. Monday's dip, in that context, looks less like a vote of no confidence and more like a pause for breath after a ferocious run-up.
